Press Releases and Announcements
Rentschler Biopharma SE to Purchase U.S. Manufacturing Site from Shire plc
December 13, 2018 Rentschler Biopharma SE appoints Biopharmaceutical Development Expert Dr. Jesús Zurdo as Senior Vice President Process Science and Innovation
Rentschler Biopharma SE announced that Dr. Jesús Zurdo will join the company as SVP Process Science and Innovation, effective January 01, 2019.
November 6, 2018 Informa 2018 Survey predicts Drug Product Formulation Recognition and Budgets to increase significantly
Rentschler Biopharma SE and LEUKOCARE AG reported results from their joint publication of the 2018 Survey ‘Formulation in the Drug Product Development Process’, based on research from Informa Pharma Intelligence.
October 18, 2018 Rentschler Biopharma and LEUKOCARE to announce findings of international Drug Product Formulation Survey at BIO-Europe 2018
The survey provides latest insights into the status quo and future of drug product formulation and its potential to refine all steps in the biopharmaceutical value chain.
September 25, 2018 Exciting lectures and stimulating exchange at the 5th Laupheim Biotech Days
The 5th Laupheim Biotech Days, a bi-annual, two-day event organized by Rentschler Biopharma, took place in Laupheim, Germany on September 20th and 21st, 2018.
September 14, 2018 2017 was another record year for medical biotechnology in Germany
The latest biotech report from vfa bio and the Boston Consulting Group on the state of medical biotechnology in Germany is now available
September 10, 2018 Interview with Dr. Frank Mathias, CEO, Dr. Ralf Otto, COO, and Federico Pollano, SVP Business Development, in European Business Magazine
From gene to vial and from clinic to market
Quality from Upper Swabia - claiming technology leadership in the pharmaceutical business
July 20, 2018 Rentschler Fill Solutions GmbH appoints Dr. Margit Klotz as General Manager Operations
Rentschler Fill Solutions GmbH announced the appointment of Dr. Margit Klotz as General Manager Operations, effective August 1, 2018.
June 28, 2018 Article in European Biotechnology Magazine Summer 2018 „Combining established and novel technologies”
An interview with Federico Pollano, SVP Business Development
June 22, 2018 Article published in the Pharma’s Almanac, June 7, 2018
“Biopharma CDMO success requires technical leadership and problem-solving capabilities”
by Federico Pollano, Senior Vice President Business Development, Rentschler Biopharma SE
June 1, 2018 Article in Journal of Biotechnology, May 2, 2018
“Multiple functions of caprylic acid-induced impurity precipitation for process intensification in monoclonal antibody purification”
by Anja Trapp, Alexander Faude, Natalie Hörold, Sven Schubert, Sabine Faust, Thilo Grob, Stefan Schmidt
May 30, 2018 Rentschler Fill Solutions and Ultragenyx start fill & finish collaboration for the US commercial supply of drug product MepseviiTM
Rentschler Fill Solutions GmbH announced a collaboration with Ultragenyx Pharmaceutical, Inc. for the drug product production of the injectable MepseviiTM (vestronidase alfa)
May 18, 2018 Costumer focus as a growth strategy
Interview with Federico Pollano in the special issue of the transkript to BIO 2018
May 11, 2018 How Rentschler Biopharma is facing the future
Presentation of Rentschler Biopharma's "Strategy 2025" at the Swiss Biotech Day 2018
With a record attendance of more than 1000 participants, the 9th German Biotechnology Days took place in Berlin on April, 18th and 19th 2018.
April 25, 2018 Rentschler Biopharma is preparing for the future
Rentschler Biopharma's CEO is presenting at the Swiss Biotech Day 2018
Focus on Biotech in Germany
April 5, 2018 Impressions from the BIO-Europe Spring in Amsterdam
Together with our strategic partners Leukocare AG and Rentschler Fill Solutions, we are looking back on very successful days at BIO-Europe Spring from March 12 to 14, 2018 in Amsterdam.
“Modular approaches for diverse molecules: reinventing smart bioprocessing”
March 28, 2018 Rentschler Biopharma SE hires Dr. Thomas Rösch as Vice President Biopharma Engineering & Technology
Rentschler Biopharma SE announced that Dr. Thomas Rösch will join the Company as Vice President Biopharma Engineering & Technology, effective April 1, 2018.
March 26, 2018 Publication in Pharm. Ind. 80, No. 2 (2018)
“Biopharmaceutical manufacturing in single-use bioreactors” by Tina Lütke-Eversloh and Peter Rogge
March 16, 2018 Join Rentschler Biopharma at the BPI West 2018
We kindly invite you to meet us at this year’s BioProcess International West conference in San Francisco, CA from March, 19th to 22nd 2018.
March 15, 2018 A streamlined mAb platform process will be presented at the Bioprocessing Summit Europe 2018
Integration of single-use adsorptive filtration as a unit operation for virus clearance
March 13, 2018 “Transkript persönlich” presents Dr. Ralf Otto
In the March issue of the German magazine Transkript, Dr. Ralf Otto, the new COO of Rentschler Biopharma SE, gives a short insight into his life in- and outside of his office.
March 9, 2018 Rentschler Biopharma and Leukocare demonstrate success of strategic alliance for biopharmaceutical development and formulation
First year of alliance delivers project wins – including four with US-based clients – proving effectiveness of new strategy
We warmly invite you to meet us at the BIO-Europe Spring in the RAI Convention Center in Amsterdam from the 12th to 14th of March.
February 28, 2018 Rentschler Biopharma SE appoints Federico Pollano as Senior Vice President, Business Development
Rentschler Biopharma SE announced that Federico Pollano has joined the Company as Senior Vice President, Business Development, effective March 1, 2018.
January 31, 2018 Rentschler Biopharma SE appoints international biopharma expert Dr. Ralf Otto as Chief Operating Officer
Rentschler Biopharma SE appointed Dr. Ralf Otto as Chief Operating Officer (COO), effective February 1, 2018.
January 29, 2018 Presentation about design, structure, and manufacturability of fusion proteins at PepTalk 2018
Improved manufacturability of designed proteins
January 18, 2018 Article in Laborwelt 2017
“Expensive affinity purification”
January 3, 2018 Presentation about smart bioprocessing strategies for fusion proteins at PepTalk 2018 in San Diego, CA
“Design, structure and manufacturability: Lessons learned from fusion proteins”
Caprylic acid-induced precipitation as beneficial tool for mAb purification design
November 29, 2017 Article in Bioprocess International Vol 15, Issue 10, November 2017
"Antibody–Drug Conjugates: Fast-Track Development from Gene to Product"
November 13, 2017 Rentschler Biopharma and its partners collectively presented themselves at BIO-Europe
Full-service at the highest quality level
November 7, 2017 Article in American Pharmaceutical Review October 2017
"Strategies to Predict the Developability of Biopharmaceuticals"
November 3, 2017 Rentschler Biopharma will present at the PEGS Europe Summit 2017
Presenting a novel approach for antibody purification
October 23, 2017 Invitation to meet Rentschler Biopharma at BIO-Europe 2017 in Berlin
World-class biomanufacturing solutions and delicious fruit juices
October 20, 2017 Great interest in CDMO Services at the BioJapan 2017
Successful conversations and speedy portraits at the Rentschler Biopharma booth
October 17, 2017 Article in European Biotechnology, Autumn 2017
"Advanced formulations for biopharmaceuticals"
October 16, 2017 Article in Bioprocess International Vol 15, Issue 8, Featured Report, September 2017
“Controlling Glycosylation in Fusion Protein Manufacturing to Generate Potent Biobetters”
October 6, 2017 Participation at two European Biotech events
Next-generation technologies and products
October 4, 2017 Rentschler Biotechnologie GmbH announces transition into a European corporation called Rentschler Biopharma SE
Rentschler Biotechnologie GmbH has successfully transitioned into a European corporation (SE) on October 1, 2017. The Company is operating as Rentschler Biopharma SE with immediate effect.
October 2, 2017 Meet Rentschler Biopharma at BioJapan 2017
Receive a personal portrait by our caricaturist
September 14, 2017 Invitation to meet Rentschler at BioProcess International 2017
Rentschler is pleased to announce its participation in the BioProcess International Conference and Exhibition, taking place from September 25 - 28, 2017 at the Hynes Convention Center in Boston, MA.
September 6, 2017 CDMOs are champions for customization of single-use equipment
Inspiring presentation at The Bioprocessing Summit in Boston, MA
September 4, 2017 Scientific Formulation Seminar & Workshop at the IZB in Martinsried
Advantages of the strategic alliance of Rentschler and Leukocare will be presented
August 18, 2017 Presenting experience with single-use systems at the BioProcessing Summit in Boston, MA
Lecture on “Disposables in bioprocessing: Catalogue or customization?”
In the beginning of August, Rentschler hosted a meeting with Dr. Nicole Hoffmeister-Kraut, Minister of Economic Affairs, Labour and Housing of Baden-Württemberg
August 7, 2017 Rentschler is growing continuously
Growth is driven by the international market
Presentation about single-use trends in development and manufacturing
Rentschler presented itself at the BIO International Convention 2017
June 13, 2017 Rentschler Biotechnologie and Rentschler Fill Solutions announce strategic partnership for one-stop solutions with new state-of-the-art fill and finish facilities
Rentschler Biotechnologie GmbH and Rentschler Fill Solutions GmbH announced a strategic partnership
Invitation to visit the Rentschler booth No 1929
May 29, 2017 A keen interest in current trends in cell culture at the 25th ESACT meeting in Lausanne
From May 14 to 17, 2017 more than 1,000 participants met for the 25th meeting of the European Society for Animal Cell Technology (ESACT) in Lausanne, Switzerland
The 25th Meeting of the European Society for Animal Cell Technology (ESACT) will be held from 14th to 17th May 2017 in Swisstech Convention Center, Lausanne, Switzerland
Presentation on fusion protein approaches to generate biobetter drugs
Exhibition booth at BIO-Europe Spring in Barcelona, Spain
March 27, 2017 Article in European Biopharmaceutical Review April 2017
“Seize the Market”
“Drivers, Opportunities, and Limits of Continuous Processing”
March 16, 2017 Participation at the Bio-Europe Spring in Barcelona, Spain
Invitation to visit the Rentschler booth No 55.
Rentschler Biotechnologie GmbH, Laupheim and Leukocare AG, Martinsried today announced a strategic alliance.
January 31, 2017 Article in Bioprocess International 14 January 2017 Featured Report
"Single-Use Depth Filters - Application in Clarifying Industrial Cell Cultures"
“Production Challenges for Complex Biologics: Fusion Proteins”
January 16, 2017 Rentschler well-represented at PepTalk 2017
Expertise in innovative protein formats highlighted in three presentations
November 18, 2016 Invitation to talk business and enjoy fruit smoothies at Bio-Europe 2016
Rentschler joined the leading European biotech business conference
November 10, 2016 Rentschler attended the largest European protein and antibody engineering conference
Presentation at the PEGS Europe
November 4, 2016 Rentschler expands cGMP manufacturing capacity following increased international demand
Second 2,000 liter single-use bioreactor put into operation. Further capacity expansion only a few weeks after putting into operation an innovative Twin system.
November 2, 2016 Participation at the Bio-Europe in Cologne, Germany
Invitation to visit the Rentschler booth No 11/12
October 20, 2016 Article in World Pharma, Vol. 2, 2016
"A proud history of progress through biotechnology"
September 16, 2016 Rentschler doubles manufacturing capacity to address growing demand for biopharmaceuticals
Innovative Twin system with two 3,000 liter bioreactors and associated downstream processing equipment put into operation. Second significant expansion in one year.
September 15, 2016 Rentschler Media Day
Rentschler has invited to a Media Day at Laupheim
September 1, 2016 Article in American Pharmaceutical Review. Vol 19, Issue 5, Jul/Aug 2016
"The Benefits and Limits of Disposable Technologies In Manufacturing Protein Therapeutics"
A pioneer in biotechnology
Press Event of IZB and BioM at Martinsried near Munich
Participation at the “Recovery XVII” in June
Artist at the booth attracted many visitors
June 17, 2016 Successful talks of drug developers, technology providers and academia at the 4th Laupheim Biotech Days
Topic: Fusion Proteins - delivering novel therapeutic options
Invitation to visit the Rentschler booth #923
April 29, 2016 Rentschler Presentations at the BPI West 2016 in Oakland, CA
Rentschler’s Turbocell™ platform and single-use vs. stainless steel decision process
February 17, 2016 Participation in 15th Annual PepTalk Protein Science Week 2016
Presentation regarding the cost constraints in therapeutic protein manufacturing
February 15, 2016 Rentschler appoints new CFO
Rentschler appoints Stefan Rampf to the position of CFO
January 29, 2016 Article in BioProcess International, Supplement Dec 2015
"The Single-Use or Stainless Steel Decision Process"
January 7, 2016 Rentschler appoints new Chief Executive Officer
Dr. Frank Mathias to become CEO of Rentschler Biotechnologie
December 15, 2015 Rentschler announces 4th Laupheim Biotech Days
The biennial scientific conference is taking place from June 13 to 14, 2016
November 30, 2015 Participation in PEGS Europe 2015
Rentschler presented at one the most important protein therapeutics development and manufacturing meetings in Europe
October 7, 2015 Probiodrug and Rentschler sign manufacturing agreement
Probiodrug signs agreement with Rentschler for manufacture of its pGlu-Abeta targeting antibody PBD-C06
October 2, 2015 Article in the European Biotechnology, Autumn Edition 2015
"Value-adding perfusion-based biomanufacturing"
Rentschler presented expertise with process platforms and modular configured processes to express and purify therapeutic Proteins
August 12, 2015 Rentschler is responsible for providing cGMP drug substance of DX-2930 for Dyax Corp.
Client News: Dyax Corp. announced today
Dyax Corp. Provides Update on DX-2930 Clinical and Commercial Supply Initiatives
June 22, 2015 Participation in PEGS Summit 2015
Rentschler presented at the essential protein engineering summit in Boston
April 14, 2015 Rentschler Biotechnologie expands European manufacturing capabilities with GE Healthcare Life Sciences bioprocess technologies
Rentschler expands manufacturing capabilities
March 23, 2015 Rentschler commissions new 2,000L single-use bioreactor
Total single-use production capacity doubled
March 2, 2015 Article in BioProcess International, Feb 2015
"Evaluating Adsorptive Filtration As a Unit Operation for Virus Removal"
January 8, 2015 Article in European Biotechnology Winter Edition 2014
"Increasing manufacturability with a modular approach"
November 26, 2014 Article in Manufacturing Chemist, Oct 2014
"Employing new single-use technology in bioprocesses"
October 16, 2014 Article in European Biotechnology, Autumn Edition 2014
"Taking mAb purification to the next level"
September 19, 2014 Rentschler presentation at The Sixth Annual Bioprocessing Summit in Boston
Highlights of the latest conference in Boston
July 16, 2014 Article in transkript, Jul/Aug 2014
"Single-Use-Bioprocesses - Hype or Future-Technology?"
Rentschler announces the building of a Twin system with two 3,000 Liter stainless steel bioreactors mainly targeting market supply
June 10, 2014 Rentschler Expands Single-Use Manufacturing Capacities
2,000 L single-use bioreactor is planned to be in operation by the beginning of 2015.
May 30, 2014 ACTIP Meeting from 12th to 13th May in Copenhagen
Top-class exchange of experiences on the topics “Glycoengineering - Better Cells for Better Products” and “Challenges with Single Use Equipment”
May 27, 2014 Article in BioProcess International, Apr 2014
"High-Cell-Density Clarification By Single-Use Diatomaceous Earth Filtration"
Rentschler presentations at conferences in London and Boston
April 15, 2014 Guest lectures at colleges and universities
Rentschler promotes the education of the next generation
Participation in international conferences and presentations of experiences and results from technology development and production.
March 14, 2014 Rentschler announces 3. Laupheimer Zelltage
“Processes for Virus-based Biologics” is the focus of this year´s 3. Laupheimer Zelltage, which will be held from June 2-3.
March 10, 2014 Article in transkript, Mar 2014
Platform technology and individual process, time-saving and cost-effective tachniques are required